AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 114 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,918,350 | -42.2% | 5,786,575 | +0.5% | 0.00% | -50.0% |
| Q2 2023 | $63,864,494 | -26.1% | 5,758,746 | +2.2% | 0.00% | -33.3% |
| Q1 2023 | $86,473,074 | -26.3% | 5,633,425 | +6.6% | 0.00% | -25.0% |
| Q4 2022 | $117,300,201 | +74.3% | 5,286,174 | +28.3% | 0.00% | +100.0% |
| Q3 2022 | $67,307,000 | +17.8% | 4,121,637 | +4.8% | 0.00% | 0.0% |
| Q2 2022 | $57,125,000 | -5.3% | 3,931,662 | +20.4% | 0.00% | 0.0% |
| Q1 2022 | $60,324,000 | -23.0% | 3,266,009 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $78,380,000 | -0.9% | 3,297,480 | +2.6% | 0.00% | 0.0% |
| Q3 2021 | $79,130,000 | +18.6% | 3,212,776 | +19.0% | 0.00% | 0.0% |
| Q2 2021 | $66,726,000 | +13.7% | 2,700,365 | +0.4% | 0.00% | 0.0% |
| Q1 2021 | $58,662,000 | +13.3% | 2,689,727 | +32.5% | 0.00% | 0.0% |
| Q4 2020 | $51,786,000 | +42.1% | 2,029,257 | +56.7% | 0.00% | +100.0% |
| Q3 2020 | $36,442,000 | +114.9% | 1,294,605 | +115.8% | 0.00% | 0.0% |
| Q2 2020 | $16,956,000 | – | 600,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 889,957 | $16,438,000 | 14.87% |
| Aaron Wealth Advisors LLC | 3,984,902 | $215,750,000 | 2.99% |
| Cormorant Asset Management, LP | 2,012,115 | $37,164,000 | 2.85% |
| GREAT POINT PARTNERS LLC | 500,000 | $9,235,000 | 2.23% |
| RTW INVESTMENTS, LP | 4,795,000 | $88,564,000 | 1.83% |
| EcoR1 Capital, LLC | 2,759,505 | $50,968,000 | 1.59% |
| 5AM Venture Management, LLC | 390,555 | $7,214,000 | 1.58% |
| Altium Capital Management LP | 243,000 | $4,488,000 | 1.50% |
| Octagon Capital Advisors LP | 321,641 | $5,941,000 | 1.28% |
| Boxer Capital, LLC | 1,121,327 | $20,711,000 | 1.06% |